Last update:
Medications news
Medications
Tiny cannabis capsules could help treat neurological diseases
A team of researchers led by Curtin University has discovered a new way to improve the absorption rate of medicinal cannabis when taken orally, which could potentially be used to treat neurological disorders such as Alzheimer's ...
Jun 18, 2021
0
22
Studies provide new evidence to battle drug price increases
Two recent studies led by researchers from the University of Minnesota Medical School add new evidence to the impact of how drug price increases affect U.S. patients and the overall cost of health care.
Jun 18, 2021
1
3
Trial results of new drug for generalized myasthenia gravis
Argenx, a Belgium pharmaceutical company, recently announced that The Lancet Neurology has published pivotal trial results from the Phase 3 ADAPT trial of efgartigimod, an FcRn antagonist, for the treatment of adults living ...
Jun 18, 2021
0
3
Eptinezumab speeds pain, symptom relief from migraine attack
(HealthDay)—Compared with placebo, treatment with intravenous eptinezumab after onset of a moderate-to-severe migraine attack shortens time to resolution of headache pain and the most bothersome symptom, according to a ...
Jun 18, 2021
0
4
New antibiotic to combat deadly bacterial 'superbugs' enters clinical trials
In a critical step toward addressing an urgent unmet medical need due to infections caused by antibiotic-resistant bacteria—also known as superbugs—a new antibiotic (QPX9003) discovered by Monash University researchers ...
Jun 18, 2021
0
5
Tweak to pritelivir allows treatment of latent herpes infections
A team of researchers at Innovative Molecules GmbH, working with several other institutions in Germany, has developed a small-molecule therapy for the treatment of latent herpes simplex virus infections. In their paper published ...
New drug class could treat range of cancers with faulty BRCA genes
Scientists have identified a new class of targeted cancer drugs that offer the potential to treat patients whose tumors have faulty copies of the BRCA cancer genes.
Jun 17, 2021
0
18
New drugs may kill and limit reproduction of bowel cancer cells
Drugs that are being trialed to treat leukemia could also be used to fight bowel cancer after a breakthrough by Hudson Institute of Medical Research scientists.
Jun 17, 2021
0
12
Family support key to overcoming barriers to HIV treatment in Africa
Researchers at the University of Missouri have found that physical mobility, transportation and financial issues pose the biggest barriers to accessing HIV treatment for older adults in South Africa, where 20 to 30 percent ...
Jun 17, 2021
0
1
Combination immunotherapy for advanced bowel cancer approved for NHS in England
People who have previously been treated for a type of bowel cancer that has spread to other parts of their body will now have another treatment option in England, following the approval of the combined use of nivolumab (Opdivo) ...
Jun 17, 2021
0
1
Inhaling antibiotics improves chest infection symptoms
The method, that uses a nebulizer to introduce antibiotics directly into the lungs, avoids many of the side effects of oral or injection medications.
Jun 17, 2021
0
3
Over-the-counter fungicide can disrupt fetal and maternal hormones
The active ingredient in medicines commonly used to treat yeast infections has the potential to disrupt steroid hormone levels, according to a study from the National Food Institute, Technical University of Denmark. This ...
Jun 16, 2021
0
4
Contraception data 'blind spot' could hide pandemic's impact on women's reproductive health
Limited data on the uptake of contraception prior to and during crises such as the COVID-19 pandemic could mean unforeseen issues for sexual and reproductive health services, research from the University of Warwick concludes.
Jun 16, 2021
0
1
FDA approval of controversial Alzheimer's drug could delay discovery of more promising treatments
The U.S. Food and Drug Administration (FDA) recently approved aducanumab, the first treatment that aims to slow the progression of Alzheimer's disease. But approval of the drug has provoked mixed reactions from the scientific ...
Jun 16, 2021
0
5
Drug reduces deaths for subset of COVID-19 patients in trial
Preliminary RECOVERY trial results find a monoclonal antibody (MAB) drug by Regeneron reduces the risk of death in a subset of patients with severe COVID-19.
Jun 16, 2021
0
4
Partisan politics and the opioid epidemic: A social media analysis
The opioid epidemic has had devastating effects in red states and blue states alike, making it a prime target for bipartisan action. But both federal and state policy have been characterized by sharp partisan differences ...
Jun 15, 2021
0
0
After the FDA's approval, what to know about the new Alzheimer's drug
In a highly anticipated announcement, the U.S. Food and Drug Administration on Monday, June 7, approved the first new drug for Alzheimer's disease in nearly two decades.
Jun 15, 2021
0
2
Opioid overdoses spiked during the COVID-19 pandemic, data show
Since the first diagnosed case of COVID-19 in the United States on Jan. 20, 2020, news about infection rates, deaths and pandemic-driven economic hardships has been part of our daily lives.
Jun 15, 2021
0
1
Ibuprofen and other NSAIDs superior to codeine for managing outpatient postoperative pain
Nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen provide better pain control and have fewer adverse effects than codeine, a commonly prescribed opioid, when prescribed after outpatient surgery, according to ...
Jun 14, 2021
0
2
